Antiallergic Medication, Vitamins and Mineral Salts, and Medications for the Treatment of Poisoning under Framework Agreement 2024/437 for the Year 2026

This tender concerns the supply of antiallergic medications, vitamins, mineral salts, and specific drugs used in the treatment of poisoning. The procurement is being conducted under the framework agreement identified as 2024/437 and is intended to cover the supply needs for the year 2026. The scope of this agreement includes a range of pharmaceutical products essential for managing allergic reactions, supporting general health through vitamin and mineral supplementation, and providing critical treatments for various intoxication cases. Potential bidders are expected to demonstrate their capacity to supply these diverse categories of medicines reliably and in compliance with all relevant pharmaceutical regulations and quality standards. The framework agreement structure suggests that multiple awards may be made, allowing for flexibility and competition among suppliers throughout the contract period. Further details regarding specific product lists, quantities, delivery schedules, and evaluation criteria will be provided in the full tender documentation. This procurement is crucial for ensuring the availability of essential medicines for public health services throughout 2026, addressing a broad spectrum of medical needs from common allergies to emergency poisoning interventions.

This is a supplies contract in the health and medical services, mining and extractives and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 8,768.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.